This test is most useful if any of these apply to you.
If you have stubborn digestive trouble, unexplained fatigue, or a close relative with celiac disease, one useful question is whether your immune system is reacting to gluten at all. This blood test looks for that reaction. A raised result is an early flag worth chasing down, not a verdict.
The catch is that this particular signal is broad. It tells you gluten is provoking an immune response, but it cannot tell you, by itself, whether that response is quietly harming your gut.
The name can be confusing. In practice, a test in this category, listed as gluten IgA or gliadin IgA, measures immunoglobulin A (IgA) antibodies that bind gluten or gliadin, a component of wheat gluten. Gluten is the storage protein of wheat and closely related grains. These antibodies are made by immune cells (B cells and plasma cells) in the lining of your gut as part of a response to gluten you have eaten.
Finding these antibodies means your immune system has responded to gluten. On its own, though, this is a general sign of gluten immune reactivity, not proof of any specific disease. That distinction shapes how much weight a single result deserves.
The condition most tied to gluten antibodies is celiac disease, where eating gluten triggers immune damage to the small intestine in genetically susceptible people (those carrying certain HLA-DQ2 or DQ8 genes). Over time this drives inflammation, flattening of the gut lining, poor nutrient absorption, anemia, and thinning bones. If your gluten IgA is raised, the most important next step is a dedicated celiac panel, because this native gluten antibody is not reliable enough to diagnose or rule out celiac disease on its own.
The reason is accuracy. Antibodies against gluten itself catch many cases but also flag people who do not have celiac disease. Testing that targets your own enzyme, called anti-tissue transglutaminase (tTG) IgA, a related but different celiac antibody, is the recommended first-line test and performs far better, reaching roughly 93 to 95 percent sensitivity and 95 to 98 percent specificity depending on the population and assay.
| What Was Measured | Celiac Cases Caught (per 100) | Healthy People Correctly Cleared (per 100) |
|---|---|---|
| Native gluten (gliadin) IgA, closest to this test | 63 | 90 |
| Deamidated gliadin IgA, a refined version | 74 | 95 |
| tTG-IgA, the standard first-line test | 78 | 98 |
Source: Rashtak et al., 2008.
What this means for you: even at its best, native gluten IgA misses roughly a third of celiac cases, so a normal result here does not clear you, and a high one does not confirm disease. If real suspicion exists, the more accurate tTG-IgA test, paired with a total serum IgA measurement, and a small-intestine biopsy when needed, settle the question.
A raised gluten IgA does not point to any particular non-celiac condition. Studies in people with IgA nephropathy, schizophrenia, autism, and bipolar disorder found that when a gluten signal appeared at all, it was usually the IgG class of antibody rather than IgA, and it was generally unrelated to celiac autoimmunity. In healthy adults, incidentally finding gluten antibodies was not linked to any measurable brain or neuropsychological problems.
In non-celiac gluten sensitivity, the more commonly detected antibody is again anti-gliadin IgG, not IgA, and no single blood marker reliably confirms that condition. So treat a positive gluten IgA as a reason to investigate celiac disease specifically, not as evidence of a broader gluten-related illness.
The single biggest trap is diet. These antibodies fall once you remove gluten and typically disappear within 3 to 9 months on a gluten-free diet. If you have already cut back on gluten, this test can read falsely normal even if you truly react to it.
A single value reflects your recent gluten intake as much as your underlying biology, because the antibody rises with exposure and falls without it. That makes the trend more informative than any one snapshot. If you are diagnosed and go gluten-free, a falling level suggests reduced gluten exposure over time, although the tTG-IgA antibody (a different but related marker) is the one clinicians usually track for diet adherence, and it normalizes in most children within about two years of going gluten-free.
A practical rhythm: get a baseline while still eating gluten, retest 3 to 6 months after any dietary change, then at least once a year. Seeing the direction of travel tells you far more than a lone number ever could.
If your gluten IgA is high, do not start a gluten-free diet yet, because that will erase the very signals needed to confirm a diagnosis. Instead, order a full celiac panel: tTG-IgA plus total serum IgA to catch IgA deficiency. If tTG-IgA is positive or clearly elevated, or if you have symptoms, involve a gastroenterologist, since a duodenal biopsy remains the reference standard when antibody levels are not conclusive.
Context changes the stakes. If you have a first-degree relative with celiac disease (about 7.5 percent of whom turn out to have it) or an autoimmune condition such as type 1 diabetes or thyroid disease, act on a positive result rather than waiting for symptoms, and consider HLA-DQ2 and DQ8 genetic testing. If your total IgA comes back low, switch to IgG-based tests such as tTG-IgG or deamidated gliadin peptide IgG, which are not fooled by IgA deficiency.
Evidence-backed interventions that affect your Gluteomorphin IgA level
Gluteomorphin IgA is best interpreted alongside these tests.
Gluteomorphin IgA is included in these pre-built panels.